Surgery: therapeutic indications

Cancer/Radiotherapie

Volumn 11, Issue 1-2, 2007, Pages 47-52

  Van Schil, P E ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Lung cancer; Staging; Surgery; Therapy

Indexed keywords

CANCER MORTALITY; CANCER STAGING; EARLY CANCER; HUMAN; LUNG LOBECTOMY; LUNG NON SMALL CELL CANCER; LUNG RESECTION; LYMPH NODE METASTASIS; MORBIDITY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; SHORT SURVEY;

CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; NEOADJUVANT THERAPY; NEOPLASM STAGING; PNEUMONECTOMY; PROGNOSIS;

EID: 34047214475     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2006.06.001     Document Type: Short Survey

References (35)

1. Albain K., Rusch V., Crowley J., Rice T., Turrisi T., Weick J., et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J. Clin. Oncol. 13 (1995) 1880-1892
2. Albain K., Swann R., Rusch V., Turrisi A., Shepherd F., Smith C., et al. Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) versus CT/RT followed by surgical resection for stage IIIA-N2 non-small cell lung cancer: outcomes update of North American Intergroup 0139 (RTOG 9309). J. Clin. Oncol. 23 (2005) 624s (abstract 7014)
3. Asamura H., Suzuki K., Watanabe S., Matsuno Y., Maeshima A., and Tsuchiya R. A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions. Ann. Thorac. Surg. 76 (2003) 1016-1022
4. Burt M., Wronski M., Arbit E., and Galicich J. Resection of brain metastases from non-small cell lung carcinoma : results of therapy. J. Thorac. Cardiovasc. Surg. 103 (1992) 399-410
5. de Perrot M., Licker M., Robert J., and Spiliopoulos A. Long-term survival after surgical resections of bronchogenic carcinoma and adrenal metastasis. Ann. Thorac. Surg. 68 (1999) 1084-1085
6. Downey R., Martini N., Rusch V., Bains M., Korst R., and Ginsberg R. Extent of chest wall invasion and survival in patients with lung cancer. Ann. Thorac. Surg. 68 (1999) 188-193
7. Gdeedo A., Van Schil P., Corthouts B., Van Mieghem F., Van Meerbeeck J., and Van Marck E. Comparison of imaging TNM [(i)TNM] and pathological TNM [pTNM] in staging of bronchogenic carcinoma. Eur. J. Cardiothorac. Surg. 12 (1997) 224-227
8. Ginsberg R., and Rubinstein L. Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Lung Cancer Study Group. Ann. Thorac. Surg. 60 (1995) 615-623
9. Graham A., Chan K., Pastorino U., and Goldstraw P. Systematic nodal dissection in the intrathoracic staging of patients with non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 117 (1999) 246-251
10. Graham E., and Singer J. Successful removal of an entire lung for carcinoma of the bronchus. JAMA 101 (1933) 1371-1374
11. Keller S., Adak S., Wagner H., and Johnson D. Mediastinal lymph node dissection improves survival in patients with stages II and IIIA non-small cell lung cancer. Ann. Thorac. Surg. 70 (2000) 358-366
12. Korst R., and Ginsberg R. Appropriate surgical treatment of resectable non-small cell lung cancer. World J. Surg. 25 (2001) 184-188
13. Liptay M. FRY W. Complications from induction regimens for thoracic malignancies. Chest Surg. Clin. N. Am. 9 (1999) 79-95
14. Martin J., Ginsberg R., Abolhoda A., Bains M., Downey R., Korst R., et al. Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy. Ann. Thorac. Surg. 72 (2001) 1149-1154
15. Mc Kenna R., Houck W., and Fuller C.B. Video-assisted thoracic surgery lobectomy: experience with 1,100 cases. Ann. Thorac. Surg. 81 (2006) 421-425
16. Mountain C. Revisions in the international system for staging lung cancer. Chest 111 (1997) 1710-1717
17. Naruke T., Suemasu K., and Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J. Thorac. Cardiovasc. Surg. 76 (1978) 832-839
18. Okada M., Yoshikawa K., Hatta T., and Tsubota N. Is segmentectomy with lymph node assessment an alternative to lobectomy for non-small cell lung cancer of 2 cm or smaller?. Ann. Thorac. Surg. 71 (2001) 956-961
19. Paulson D., and Urschel H. Selectivity in the treatment of bronchogenic carcinoma. J. Thorac. Cardiovasc. Surg. 62 (1971) 554-562
20. Rami-Porta R., Wittekind C., and Goldstraw P. International Association for the Study of Lung Cancer (IASLC) Staging Committee. Complete resection in lung cancer surgery: proposed definition. Lung Cancer 49 (2005) 25-33
21. Reif M., Socinski M., and Rivera M. Evidence-based medicine in the treatment of non-small cell lung cancer. Clin. Chest Med. 21 (2000) 107-120
22. Rendina E., Venuta F., De Giacomo T., Ciacone A., Moretti M., Ruvolo G., et al. Sleeve resection and prosthetic reconstruction of the pulmonary artery for lung cancer. Ann. Thorac. Surg. 68 (1999) 995-1001
23. Riquet M., Manac'h D., Le Pimpec-Barthes F., Dujon A., and Chehab A. Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung. Ann. Thorac. Surg. 67 (1999) 1572-1576
24. Rusch V., Giroux D., Kraut M., Crowley J., Hazuka M., Johnson D., et al. Induction chemoradiation and surgical resection for non-small cell lung carcinomas of the superior sulcus: initial results of southwest oncology group trial 9416 (intergroup trial 0160). J. Thorac. Cardiovasc. Surg. 121 (2001) 472-483
25. Rusch V., Albain K., Turrisi A., Swann S., Shepherd F., Chen Y., et al. Phase III trial of concurrent chemotherapy and radiotherapy (CT/RT) versus CT/RT followed by surgical resection for stage IIIA-N2 non-small cell lung cancer: outcomes and implications for surgical management in North American Intergroup 0139 (RTOG 9309). Lung Cancer 49 (2005) S15 (abstract O-035)
26. Sakao Y., Miyamoto H., Yamazaki A., Oh T., Fukai R., Shiomi K., et al. Prognostic significance of metastasis to the highest mediastinal lymph node in non-small cell lung cancer. Ann. Thorac. Surg. 81 (2006) 292-297
27. Siegenthaler M., Pisters K., Merriman K., Roth J., Swisher S., Walsh G., et al. Preoperative chemotherapy for lung cancer does not increase surgical morbidity. Ann. Thorac. Surg. 71 (2001) 1105-1112
28. Van Meerbeeck J., Kramer G., Van Schil P., Legrand C., Smit E., Schramel F., et al. A randomized trial of radical surgery versus thoracic radiotherapy in patients with stage IIIA-N2 non-small cell lung cancer after response to induction chemotherapy (EORTC 08941). J. Clin. Oncol. 23 (2005) 1095s (abstract 7015)
29. Van Schil P. Role of video-assisted thoracic surgery (VATS) in staging, diagnosis and treatment of lung cancer. Acta Chir. Belg. 99 (1999) 103-108
30. Van Schil P., Van den Brande F., and De Maeseneer M. Operative staging of lung cancer. Monaldi Arch. Chest Dis. 55 (2000) 299-304
31. Van Schil P., Vankeirsbilck J., Brutel de la Rivière A., and Van den Bosch J. Long-term survival after bronchial sleeve resection in relation to nodal involvement. Eur. J. Cardiothorac. Surg. 17 (2000) 196-197
32. Van Schil P. Surgery for non-small cell lung cancer. Lung Cancer 34 (2001) S127-S132
33. Van Schil P., Van Meerbeeck J., Kramer G., Splinter T., Legrand C., Giaccone G., et al. Morbidity and mortality in the surgery arm of EORTC 08941 trial. Eur. Resp. J. 26 (2005) 192-197
34. Veronesi G., Solli P., Leo F., D'Aiuto M., Pelosi G., Leon M., et al. Low morbidity of bronchoplastic procedures after chemotherapy for lung cancer. Lung Cancer 36 (2002) 91-97
35. Wu Y., Huang Z., Wang S., Yang X., and Ou W. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer 36 (2002) 1-6